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Objectives: To explore the factors concerning postdischarge rehospitalization and in-hospital mortality
among Taiwanese women older than 50 years with hip fracture.
Materials and methods: The National Health Insurance database from 2000 to 2006 was used to identity
relevant cases. Women inpatients aged over 50 years with new-onset hip fracture in 2003 were iden-
tiﬁed. We analyzed the factors affecting postdischarge rehospitalization and in-hospital mortality.
Results: In 2003, there were 9467 new-onset hip fracture inpatients claimed among Taiwanese women
aged over 50 years. The 3-year cumulative rates of rehospitalization after discharge and in-hospital
mortality rate were 11.01% (1043) and 7.10% (672), respectively. The factors determined to be related
to rehospitalization were patient age, hospital level, length of stay of the initial hospitalization due to hip
fracture, and Charlson comorbidity index (CCI) score. The factors determined to be related to in-hospital
mortality were age, urbanization level of region where patients were insured, hospital level, length of
stay of the initial hospitalization due to hip fracture, and CCI score.
Conclusion: Characteristics of women aged over 50 years with hip fracture remain an important issue
based on high rehospitalization and in-hospital mortality rates. We have identiﬁed related risk factors
that may be helpful in treating hip fracture among this population segment.
Copyright  2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Taiwan is undergoing a signiﬁcant demographic shift in its
population. Like many developed countries, its elderly population
is rapidly growing. The increased life expectancy of its people has
engendered higher incidences of several chronic diseases, including
osteoporosis. Another disease, hip fracture resulting from osteo-
porosis, is a major global and national health problem among
elderly [1e3]. In 1990, the prevalence of hip fracture worldwide
was estimated at 1.26 million, and is predicted to reach 6.3 million
by 2050 [4,5].Management, National Taipei
ang Street, Wan-Hua District,
.
bstetrics & Gynecology. PublishedAlthoughurgent care and surgical techniques for hip fracture have
improved, mortality and morbidity following hip fracture remains
high,with1st-yearmortality rates followinghip fracturebetween26%
and 33% [6e9]. In addition, >50% of patients who experience hip
fracture do not regain normal body functions [10e12]. Moreover, up
to 25% must stay in a dependent residence or long-term care facility
for >1 year [9,12].
Compared to male instances, hip fracture rates in females are
much higher [13]. The population of Taiwanese women aged over
50 years has grown rapidly from 1.74million in 1992 to 3.25 million
in 2008 [14]. Hip fracture in elderly women imposes a heavy
burden on the health care delivery system, and during this period,
has increased in incidence at an annual rate of 2.8%. Inpatient ser-
vices for fractures cost the National Health Insurance around NTD 6
billion annually, with hip fractures accounting for 20% of all frac-
tures. Such high costs have illuminated this issue to the public,
meriting thorough investigation [15].by Elsevier Taiwan LLC. All rights reserved.
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hip fracture in females [16,17], treatment strategies for hip fracture
[18], prognosis of hip fracture in terms of various prehospitalization
variables [19], and health care expenditures including costs of
rehospitalization, and inpatient services associated with hip frac-
ture [20]. However, few studies have adopted a national database to
identify factors associated with rehospitalization and in-hospital
mortality regarding hip fracture in females. This study is an
investigation of the short- and long-term rates of rehospitalization
and in-hospital mortality for Taiwanese women older than 50 years
whowere discharged from a newly onset hip fracture. In addition, it
reveals possible factors affecting in-hospital and rehospitalization
mortality.Materials and methods
Study design and data sources
The present study was based on a retrospective cohort design
whose data were extracted from a registry of beneﬁciaries, con-
tractedmedical facilities, and inpatient expenditures between 2000
and 2006 in the National Health Insurance (NHI) database. Infor-
mation concerning illness, e.g., hip-fracture hospitalization and in-
hospital mortality during the follow-up period was retrieved from
inpatient expenditures by admissions ﬁles between 2000 and 2006.
Moreover, the hospital level of themedical institutionsdsites of the
ﬁrst hip-fracture hospitalization of the study participants in
2003dwas acquired from the registry for contracted medical fa-
cilities ﬁles in 2003. Finally, the gender, dates of birth, urbanization
of the insurance locations, and potential cancellation dates prior to
the end of 2006 were obtained from the registry for beneﬁciary’s
ﬁles.
The NHI database has been routinely collected by the National
Health Research Institutes and supervised by the state-run Bureau
of NHI, which has implemented a universal health program in
Taiwan since March 1995. By the end of 1996, approximately 96% of
the Taiwanese population had enrolled in the NHI program, with
97% of hospitals and clinics contracting with NHI throughout
Taiwan [21].Study participants
Firstly, 10,620 patients were selected as qualiﬁed samples based
on a selection criteria of females with the diagnosis codes of hip
fracture (ICD9 820.0, 820.1, 820.2, 820.3, 820.8, 820.9, 820.20,
820.21, 820.30, and 820.31) in one primary diagnosis or four sec-
ondary diagnoses in the detailed National Health Insurance inpa-
tient expenditures by admissions ﬁles in 2003. Secondly, some
samples were discarded based on exclusion criteria, including: (1)
hospitalization death at that time (74 patients); (2) age < 50 years
(455 patients) - because osteoporosis-induced hip fracture usually
occurs in women aged < 50 years, especially those experiencing
menopause; and (3) previous hospitalization due to hip fracture
(ICD9 820) or pathological fracture (ICD9 733.14, 733.15) between
2000 and 2002 (624 patients), in order that patients were selected
with a new-onset hip fracture. In total, 9467 patients were chosen.
A registry of beneﬁciaries contains data involving the location of
each member’s NHI unit. It may be detailed as the beneﬁciaries’
residential area or simply their location of employment. Thus, the
area of each member’s NHI unit is divided into four geographic
areas (i.e., northern area, central area, southern area, and eastern
area) or three urbanization statuses (i.e., metropolitan area, satel-
lite area, and rural area) according to the National Statistics of
Regional Standard Classiﬁcation [22].Comorbidity severity
The Charlson Comorbidity Index (CCI) is a measurement of hip
fracture severity. Deyo coding [23] was used to group severity
based on the hospitalization data in the year prior to hospitalization
due to hip fracture in 2003. Comorbidity severity increased with
increasing score [24]. For this study, the CCI score was divided into
three groups (0, 1, and 2).
In-hospital mortality and rehospitalization incidence
In this study, the in-hospital mortality was based on the patients
with new-onset hip fracture in 2003. The cumulative incidences of
in-hospital mortality (including all causes of mortality) occurring
during each period (30 days, 1 year, and 3 years) were calculated
accordingly. By contrast, the rehospitalization is deﬁned as the
patients with a new-onset hip fracture discharged from the hos-
pital. The cumulative incidences of rehospitalization due to hip
fracture during each period (14 days, 30 days, 1 year, and 3 years)
were calculated.
Statistical analysis
At ﬁrst, a descriptive statistics package described the mean
values and standard deviations of continuous variables (age, length
of stay, CCI, and medical costs), and the case numbers and per-
centage distributions of categorical variables for the fundamental
attributes of the study participants. In bivariate analysis, the t and
Chi-square tests were performed for the continuous and categorical
variables described above to investigate the difference between a
group of women aged <75 years and a group aged 75 years.
The multiple variable Cox proportional hazard model was used
to analyze the relationship between the personal and institutional
levels of in-hospital mortality and rehospitalization risks of pa-
tients with hip fracture. Moreover, the relative risk of each variable
for in-hospital and rehospitalization was estimated.
A Cox regression analysis used data starting from the discharge
date of the patient with a hip fracture and being hospitalized for the
ﬁrst time until the ending time (t1) that was determined based on:
(1) the date that the patient died or was rehospitalized; (2) the
patient’s insurance cancellation date, if it came prior to the date of
in-hospital mortality or rehospitalization due to hip fracture during
the study period; and (3) the date that the data were censored
when in-hospital mortality or rehospitalization owing to hip frac-
ture occurred if the participant did not cancel the insurance during
the study period.
Results
As shown in Table 1, a total of 9467 females in Taiwan aged >50
years and hospitalized due to new-onset hip fracture in 2003 were
selected and categorized into two groups: those aged from 50 years
to 74 years and those over 75 years. The age 50e74 years group
included 3391 patients (35.82%), with 6076 patients (64.18%) in the
other group. Using a t test, this study discovered that no signiﬁcant
differences exist between the two groups regarding geographic
regions, length of stay, and 30-day in-hospital mortality. By
contrast, the level of urbanization and other variables displayed
signiﬁcant differences. With respect to the CCI score, the 50e74
year group was signiﬁcantly higher than the elder group (aged over
75 years), although the elder group demonstrated higher in-
cidences of 14-day, 30-day, 1-year, and 3-year cumulative reho-
spitalization, higher incidences of 1-year and 3-year cumulative
mortality, and lower medical costs for ﬁrst hospitalization. The
Table 1
Basic participant characteristics in 2003.a
50e74 y
(n ¼ 3391)
75 y
(n ¼ 6076)
p
n (%) n (%)
Age
Mean (SD) 67.22 (6.14) 82.87 (5.38) <0.001
Geographic region 0.39
Northern 1343 39.82 2367 39.37
Central 905 26.83 1708 28.41
Southern 1016 30.12 1743 28.99
Eastern 109 3.23 194 3.23
Urbanization level <0.01
Metropolitan areas 1228 36.21 2061 33.92
Satellite cities or towns 876 25.83 1499 24.67
Rural areas 1287 37.96 2516 41.41
Hospital level <0.001
Medical center 992 29.25 1572 25.87
Regional hospital 1374 40.52 2461 40.50
District hospital 1025 30.23 2043 33.63
Length of stay <0.001
1e10 d 2074 61.16 3428 56.42
11 d 1317 38.84 2648 43.58
Mean (SD) 9.83 (8.28) 10.09 (7.45) 0.14
CCI score <0.001
0 1899 56.00 3685 60.65
1 230 6.78 741 12.20
2 1262 37.22 1650 27.15
Mean (SD) 1.41 (2.22) 1.02 (1.76) <0.001
Rehospitalization
14-d 109 3.21 253 4.16 0.02
30-d 130 3.83 296 4.87 0.02
1-y 204 6.02 509 8.38 <0.001
3-y 304 8.96 739 12.16 <0.001
In-hospital mortality
30-d 8 0.24 24 0.39 0.20
1-y 70 2.06 187 3.08 <0.001
3-y 175 5.16 497 8.18 <0.001
Medical costs, NTD
Mean (SD) 76,583
(58,586)
68,451
(53,318)
<0.001
CCI ¼ Charlson Comorbidity Index; SD ¼ standard deviation.
a For certain columns, the total number is not equal to the sum of the number of
samples because of missing values.
Table 2
Factors associated with in-hospital mortality after hip fracture.
Demographics 30-d 1-y
AHR (95% CI) p AH
Age
<75 y 1.00 1.0
75 y 1.88 (0.83e4.23) 0.13 1.7
Geographic region
Northern 1.00 1.0
Central 1.04 (0.38e2.85) 0.94 0.6
Southern 0.71 (0.27e1.85) 0.48 0.9
Eastern 1.22 (0.14e10.96) 0.86 1.8
Urbanization level
Metropolitan areas 1.00 1.0
Satellite cities 0.87 (0.36e2.13) 0.76 0.7
Rural areas 0.60 (0.22e1.63) 0.32 0.3
Hospital level
Medical center 1.00 1.0
Regional hospital 2.08 (0.67e6.48) 0.21 0.9
District hospital 3.94 (1.28e12.13) 0.02 1.3
Length of stay
1e10 d 1.00 1.0
11 d 0.73 (0.35e1.51) 0.40 1.4
CCI score
0 1.00 1.0
1 3.28 (0.96e11.25) 0.06 2.4
2 6.59 (2.76e15.70) <0.001 3.2
AHR ¼ adjusted hazard ratio; CCI ¼ Charlson Comorbidity Index; CI ¼ conﬁdence interv
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among the elder group.
Table 2 summarizes possible factors for explaining in-hospital
mortality. All the variablesdincluding age, geographic region, level
of urbanization, hospital level, length of stay, and CCI scoredare
shown to impact in-hospitalmortality signiﬁcantly. The elder group’s
risk of mortality is much higher, 1.88-fold, 1.74-fold, and 1.94-fold of
the age 50e75 year group for a 30-day,1-year, and 3-year cumulative
mortality, respectively. The patients from the central region have
signiﬁcantly lower 3-year cumulative in-hospital mortality than pa-
tients from the northern region. Levels of urbanization negatively
impacts the 3-year cumulative in-hospital mortality. Meanwhile,
patients from satellite cities and rural areas have signiﬁcantly lower
mortality than patients from metropolitan areas. Patients treated in
district hospitals have signiﬁcantly higher 3-year cumulative in-
hospital mortality than those in medical centers. Longer stays dur-
ing the ﬁrst admission displayed signiﬁcantly higher incidences of 3-
year mortality. Comorbidity also was an important factor in in-
hospital mortality. For instance, the cumulative in-hospital mortal-
ity of 30-days was high; however, a decreasing trend accompanied
the increasing interval of rehospitalization. A higher CCI score may
lead to a signiﬁcantly higher cumulative in-hospital mortality. Pa-
tients with a CCI score > 2 had a 2.58-fold higher of risk of dying in
hospital within 3 years compared to a CCI score 0; meanwhile, their
risk of in-hospital mortality was 6.59-fold and 3.25-fold higher
within 30 days and 1 year, respectively.
Table 3 summarizes the possible factors associated with reho-
spitalization. The t test revealed that age, hospital level, length of
stay, and CCI score signiﬁcantly impact rehospitalization ﬁgures.
The elder group, the district hospital, and short stay had signiﬁcant
higher incidences of rehospitalization. Regarding comorbidity, pa-
tients with a CCI score > 2 had signiﬁcantly higher rehospitaliza-
tion rates over time.Discussion
This study used the inpatient dataset of NHI Research Database
to examine the factors associated with rehospitalization and in-3-y
R (95% CI) p AHR (95% CI) p
0 1.00
4 (1.32e2.30) <0.001 1.94 (1.63e2.31) <0.001
0 1.00
9 (0.46e1.02) 0.06 0.68 (0.54e0.86) <0.001
0 (0.67e1.23) 0.52 0.90 (0.75e1.09) 0.28
3 (0.86e3.91) 0.12 1.31 (0.78e2.19) 0.30
0 1.00
2 (0.53e0.96) 0.03 0.67 (0.56e0.80) <0.001
7 (0.25e0.54) <0.001 0.43 (0.34e0.54) <0.001
0 1.00
9 (0.73e1.34) 0.95 1.08 (0.89e1.31) 0.45
8 (1.00e1.91) 0.05 1.51 (1.23e1.85) <0.001
0 1.00
3 (1.11e1.83) 0.01 1.24 (1.07e1.45) <0.01
0 1.00
9 (1.69e3.66) <0.001 1.88 (1.47e2.40) <0.001
5 (2.47e4.27) <0.001 2.58 (2.19e3.04) <0.001
al.
Table 3
Factors associated with rehospitalization after hip fracture.
Demographics 14-d 30-d 1-y 3-y
AHR (95% CI) p AHR (95% CI) p AHR (95% CI) p AHR (95% CI) p
Age
<75 y 1.00 1.00 1.00 1.00
75 y 1.36 (1.08e1.71) <0.01 1.34 (1.07e1.62) <0.01 1.46 (1.24e1.73) <0.01 1.50 (1.31e1.72) <0.001
Geographic regions
Northern 1.00 1.00 1.00 1.00
Central 1.21 (0.89e1.64) 0.24 1.25 (0.94e1.67) 0.12 1.12 (0.90e1.39) 0.32 1.01 (0.85e1.21) 0.89
Southern 1.17 (0.89e1.54) 0.26 1.20 (0.93e1.54) 0.16 1.07 (0.88e1.29) 0.52 1.03 (0.88e1.21) 0.73
Eastern 0.96 (0.47e1.96) 0.90 1.00 (0.52e1.92) 0.99 0.89 (0.54e1.46) 0.65 0.83 (0.55e1.26) 0.38
Urbanization level
Metropolitan areas 1.00 1.00 1.00 1.00
Satellite cities 1.01 (0.76e1.33) 0.97 0.96 (0.74e1.24) 0.73 0.98 (0.80e1.20) 0.85 0.94 (0.80e1.10) 0.43
Rural areas 0.87 (0.66e1.16) 0.36 0.88 (0.68e1.14) 0.33 0.99 (0.81e1.21) 0.91 0.98 (0.83e1.16) 0.84
Hospital level
Medical center 1.00 1.00 1.00 1.00
Regional hospital 1.56 (1.08e2.25) 0.02 1.51 (1.10e2.09) 0.01 1.18 (0.95e1.47) 0.13 1.18 (0.99e1.39) 0.06
District hospital 4.47 (3.20e6.26) <0.001 3.82 (2.83e5.14) <0.001 2.24 (1.82e2.75) <0.001 1.95 (1.65e2.31) <0.001
Length of stay
1e10 d 1.00 1.00 1.00 1.00
11 d 0.25 (0.19e0.34) <0.001 0.32 (0.25e0.41) <0.001 0.51 (0.43e0.60) <0.001 0.64 (0.56e0.73) <0.001
CCI score
0 1.00 1.00 1.00 1.00
1 1.16 (0.81e1.65) 0.43 1.19 (0.86e1.66) 0.29 1.19 (0.93e1.52) 0.16 1.15 (0.94e1.41) 0.17
2 1.53 (1.22e1.92) <0.001 1.60 (1.30e1.97) <0.001 1.28 (1.09e1.51) <0.001 1.19 (1.04e1.37) 0.01
AHR ¼ adjusted hazard ratio; CCI ¼ Charlson Comorbidity Index; CI ¼ conﬁdence interval.
H.-J. Jou et al. / Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 43e4746hospital mortality after the ﬁrst discharge due to hip fracture for
female patients aged >50 years. Many previous studies have
focused on the mortality or in-hospital mortality of patients within
1 year of undergoing hip fracture surgery; however, few have
examined the risk of rehospitalization. In this study, using a na-
tional database, we extended the follow-up period to 3 years from
ﬁrst hospitalization. In addition, the previous studies mainly
focused on the impact of patient demographics, surgery methods,
postsurgical complications, and time from the frequency of hip
fracture surgery on mortality.
This study revealed that age, hospital level, length of stay of
initial hospitalization due to hip fracture, and CCI score were
signiﬁcantly associated with rehospitalization. In-hospital mortal-
ity was signiﬁcantly associated with age, level of urbanization of
regionwhere patients were insured, hospital level, length of stay of
the initial hospitalization due to hip fracture, and CCI score. This
study revealed that the patient’s age signiﬁcantly inﬂuenced
rehospitalization and in-hospital mortality. Regardless of the
length of observation period, the rehospitalization and in-hospital
mortality of groups aged over 75 years were signiﬁcant higher
than the group aged 50e74 years. This ﬁnding was similar to the
study by Paksima et al [25]. In addition, the risk of fracture was
previously shown to increase with age exponentially [15], and
others have demonstrated that age is a major predictor of mortality
rate [25,26].
Our study found that age not only impacted on short-term
mortality but also on long-term mortality. For example, the group
aged over 75 years had a 1.74 times increased risk of 1-year mor-
tality. Elderly patients were associated with a greater risk of mor-
tality after hip fracture as well as an increased risk of
rehospitalization, risk that was 1.36e1.50 times greater than the
other group.
Moreover, this study found that patients in central Taiwan had a
signiﬁcantly lower in-hospital mortality than patients in northern
Taiwan, with in-hospital mortality rates within metropolitan areas
signiﬁcantly higher than those in satellite cities and rural areas. A
previous study regarding cancer mortality in Taiwan showed that
the mortality rate of cancer was signiﬁcantly higher in populationsfrom metropolitan areas than those within rural areas, with the
quality of life in follow-up care potentially contributing to this
difference [27]. Tsai et al [28] showed that compared to elderly
persons living in urban or rural areas, those living on remote islands
have signiﬁcantly better mobility and mental health, which could
decrease mortality rate. Leung et al [29] found that residents of
metropolitan areas walk faster due to their lifestyle habits and are
therefore at risk of suffering fall-related injuries more easily. In
addition, the heavy stress of life in metropolitan areas may affect
their health status [29]. Residents of satellite cities or rural areas are
more likely to live with families, and therefore may obtain better
home care after hospital discharge. A study reveals that elderly
persons who live alone in rural places have a better quality of life
than those living in care centers [30].
This study indicates that patients treated in district hospitals
have a higher risk of rehospitalization and in-hospital mortality
than those treated in medical centers, with the hospital scale (a
medical center has 500 beds; regional hospital  300 beds; and
district hospital  100 beds) affecting the hip fracture prognosis.
This ﬁnding is consistent with that of Soohoo et al [31], who
discovered that hospital volume was the strongest predictor of 90-
day postsurgical complications among 138,399 patients who had
received total hip arthroplasty. The reason could be that the smaller
scale of district hospitals limits their ability to offer professional
specialties, equipment, and management measures compared to
medical centers, thus affecting patient prognosis [32]. For hip
fracture patients, a length of stay during the ﬁrst hospitalization
that exceeds 11 days has a lower risk of rehospitalization; however,
in-hospital mortality is higherdexcluding a rehospitalization of
30-days. It is difﬁcult to explain these contradictory results. Thus,
advanced data are needed for conﬁrmation.
Previous investigations have pointed out that comorbidity is an
important factor that impacts hip fracture prognosis [33,34]. A
study by Michel et al [34] demonstrated that patients with a high
American Society of Anesthesia’s rating of operative risk (score 3 or
4) had a nine times greater 1st-year mortality after operations for
hip fracture. In our study, rehospitalization and in-hospital mor-
tality have higher risks than others when the CCI score exceeded 2.
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Paksima et al [25] highlighted that patients with chronic obstruc-
tive pulmonary disease, congestive heart failure, or a cancer history
were signiﬁcantly associated with an elevated mortality risk. The
consistency between the results from Paksima’s study [25] and our
study merits further investigation. Nevertheless, most studies
suggest that comorbidity severity is an important factor that affects
the prognosis of hip fracture. We believe that it may be an impor-
tant issue to manage comorbidities when treating a hip fracture.
In this study, we used the NHI database to analyze the factors
associated with in-hospital mortality and rehospitalization after
hip fracture to reveal that different factors may yield different
impacts on in-hospital mortality and rehospitalization after a hip
fracture. In addition to considering demographic factors, these re-
sults highlight the inﬂuence of hospital management on rehospi-
talization. The results may serve as an important criterion for
health policymakers to reformmedical policy and improvemedical
services performance.
Nevertheless, the study featured several limitations. First, it lacked
data pertaining to menopause or the use of hormone replacement
therapy. Additional information such as lifestyle (including diet and
external environment), health behavior, and health status were un-
available and could only be generalized from other studies. Second,
the study dataset only contained claim data for inpatient services.
Data of mortality statistics out of hospitals was unavailable and
therefore adopted in-hospital mortality data may have under-
estimated the real mortality rates of patients. However, given the
convenience and inexpensive service fee for medical care in Taiwan,
patientswho experience hip fracture should be able to obtainprompt
inpatient treatment. Hence, the gap between in-hospital mortality
and real mortality may not be signiﬁcant. Third, although the study
excluded patients who had been hospitalized for hip fracture
(ICD820) or pathological fracture (ICD9 733.14, 733.15), we could not
conﬁrm that patients who were hospitalized in 2003 had previously
had a history of hospitalization due to hip fracture.
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